Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/16/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/16/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/16/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/16/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/16/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/14/18 | SC TO-I/A | Issuer tender offer statement |
|
4 | |
| 02/13/18 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
7 | |
| 02/13/18 | 8-K | Current report filing |
|
3 | |
| 02/09/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/09/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
